File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Differential DNA Methylation Profiles in Gynecologic Cancers

TitleDifferential DNA Methylation Profiles in Gynecologic Cancers
Authors
Issue Date2004
PublisherAmerican Association for Cancer Research
Citation
AACR 95th Annual Meeting, Orlando FL, 27–31 March 2004. In Cancer Research, 2004, v. 64 n. 7S, p. 267 Abstract no. 1168 How to Cite?
AbstractCpG island hypermethylation of cancer-related genes is a frequent epigenetic event in human cancers. The present study was to determine the CpG island methylation profiles in gynecologic cancers; and to identify potential targets for cancer management. Methylation status for 34 loci was examined in differential DNA pools representing tumor and normal DNA from 50 cervical cancer, 50 endometrial cancer and 50 ovarian cancers by methylation specific polymerase chain reaction. Methylated alleles detected in tumor but not in normal DNA indicated the occurrence of aberrant methylation in tumors. Multiple genes were methylated in the three cancers. P16 and APC were methylated across the three cancers. MINT31 and PTEN were methylated in cervical and ovarian cancers. And RAR-β2 was methylated in ovarian and endometrial cancer. Specific methylation was also found in cervical cancer (including CDH1, DAPK, HIC-1, MGMT, MINT1, MINT2 and RASSF1A), in endometrial cancer (including CASP8, CDH13, hMLH1 and p73), and ovarian cancer (including BRCA1, p14, p15, RIZ1 and TMS1). Furthermore, incidence of methylation for DAPK, MGMT, p16 and PTEN in 127 cervical cancers; APC, CDH13, hMLH1 and p16 in 60 endometrial cancer; and BRCA1, p14, p16 and PTEN in 50 ovarian cancers, was determined. Incidence varied among different genes and in different cancer types ranging from the lowest 8.0% (PTEN in ovarian cancer) to the highest 56.7% (DAPK in cervical cancer). Methylation of some specific loci was related to particular tumor subtypes. In cervical cancer, DAPK methylation was more frequently detected in squamous cell carcinoma (SCC) than in adenocarcinoma (AC), whereas PTEN methylation was more frequent in AC than in SCC (P<0.01, respectively). And a significant correlation was observed between MGMT methylation and early-stage tumor (P=0.03). In ovarian cancer, methylation of BRCA1 was significantly associated with serous carcinoma, while PTEN was associated with mucinous carcinoma (P=0.02, respectively). And P14 methylation was more common in low-grade tumor (p=0.02) and early-stage tumor (P=0.04). In endometrial cancer, hMLH1 methylation was detected at a significantly higher frequency in high-grade tumor (P<0.01); p16 methylation was only present in stage I carcinoma (p=0.01). In addition, DAPK methylation was independently associated with shorter disease free survival by multivariate analysis and PTEN methylation was related to radiosensitivity in cervical cancer. Thus, differential methylation profiles occur in the three types of gynecologic cancers. Detection of methylation for critical loci is potentially useful as epigenetic markers in tumor classification, prognosis and predicting therapeutic response in gynecologic cancers.
Persistent Identifierhttp://hdl.handle.net/10722/113705
ISSN
2015 Impact Factor: 8.556
2015 SCImago Journal Rankings: 5.372

 

DC FieldValueLanguage
dc.contributor.authorYang, Hen_HK
dc.contributor.authorLiu, VWSen_HK
dc.contributor.authorWang, Yen_HK
dc.contributor.authorNgan, HYSen_HK
dc.date.accessioned2010-09-26T04:27:35Z-
dc.date.available2010-09-26T04:27:35Z-
dc.date.issued2004en_HK
dc.identifier.citationAACR 95th Annual Meeting, Orlando FL, 27–31 March 2004. In Cancer Research, 2004, v. 64 n. 7S, p. 267 Abstract no. 1168-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/113705-
dc.description.abstractCpG island hypermethylation of cancer-related genes is a frequent epigenetic event in human cancers. The present study was to determine the CpG island methylation profiles in gynecologic cancers; and to identify potential targets for cancer management. Methylation status for 34 loci was examined in differential DNA pools representing tumor and normal DNA from 50 cervical cancer, 50 endometrial cancer and 50 ovarian cancers by methylation specific polymerase chain reaction. Methylated alleles detected in tumor but not in normal DNA indicated the occurrence of aberrant methylation in tumors. Multiple genes were methylated in the three cancers. P16 and APC were methylated across the three cancers. MINT31 and PTEN were methylated in cervical and ovarian cancers. And RAR-β2 was methylated in ovarian and endometrial cancer. Specific methylation was also found in cervical cancer (including CDH1, DAPK, HIC-1, MGMT, MINT1, MINT2 and RASSF1A), in endometrial cancer (including CASP8, CDH13, hMLH1 and p73), and ovarian cancer (including BRCA1, p14, p15, RIZ1 and TMS1). Furthermore, incidence of methylation for DAPK, MGMT, p16 and PTEN in 127 cervical cancers; APC, CDH13, hMLH1 and p16 in 60 endometrial cancer; and BRCA1, p14, p16 and PTEN in 50 ovarian cancers, was determined. Incidence varied among different genes and in different cancer types ranging from the lowest 8.0% (PTEN in ovarian cancer) to the highest 56.7% (DAPK in cervical cancer). Methylation of some specific loci was related to particular tumor subtypes. In cervical cancer, DAPK methylation was more frequently detected in squamous cell carcinoma (SCC) than in adenocarcinoma (AC), whereas PTEN methylation was more frequent in AC than in SCC (P<0.01, respectively). And a significant correlation was observed between MGMT methylation and early-stage tumor (P=0.03). In ovarian cancer, methylation of BRCA1 was significantly associated with serous carcinoma, while PTEN was associated with mucinous carcinoma (P=0.02, respectively). And P14 methylation was more common in low-grade tumor (p=0.02) and early-stage tumor (P=0.04). In endometrial cancer, hMLH1 methylation was detected at a significantly higher frequency in high-grade tumor (P<0.01); p16 methylation was only present in stage I carcinoma (p=0.01). In addition, DAPK methylation was independently associated with shorter disease free survival by multivariate analysis and PTEN methylation was related to radiosensitivity in cervical cancer. Thus, differential methylation profiles occur in the three types of gynecologic cancers. Detection of methylation for critical loci is potentially useful as epigenetic markers in tumor classification, prognosis and predicting therapeutic response in gynecologic cancers.-
dc.languageengen_HK
dc.publisherAmerican Association for Cancer Research-
dc.relation.ispartofCancer Researchen_HK
dc.titleDifferential DNA Methylation Profiles in Gynecologic Cancersen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLiu, VWS: vwsliu@hkusua.hku.hken_HK
dc.identifier.emailNgan, HYS: hysngan@hkucc.hku.hken_HK
dc.identifier.authorityLiu, VWS=rp00341en_HK
dc.identifier.authorityNgan, HYS=rp00346en_HK
dc.identifier.hkuros113325en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats